Centene Corporation (CNC) is a U.S.-based healthcare enterprise with a market cap of $19.1 billion, serving under-insured and uninsured individuals. It operates through four segments and has seen its shares drop 41.9% from its 52-week high. Despite fluctuations, it has been trading below its moving averages since last year.

Centene’s shares jumped 12.5% on Oct. 29 after raising its 2025 profit forecast to at least $2 per share, surpassing estimates. The company also beat expectations with Q3 2025 adjusted EPS of $0.50. Analysts remain cautious due to the stock’s weak performance, with a consensus rating of “Hold” and a mean price target of $40.53.

Elevance Health, Inc. (ELV) has shown a less pronounced decline compared to Centene. ELV stock has decreased 10.3% on a YTD basis and nearly 19% over the past 52 weeks. Despite Centene’s recent performance, analysts are cautious, with a consensus rating of “Hold” and a mean price target of $40.53.

Read more at Yahoo Finance: Is Centene Stock Underperforming the S&P 500?